Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

In Vitro and In Vivo antifungal activities of selected Cameroonian dietary spices

  • Jean Paul Dzoyem1Email author,
  • Roland T Tchuenguem1,
  • Jules R Kuiate1,
  • Gerald N Teke2,
  • Frederick A Kechia2 and
  • Victor Kuete1
BMC Complementary and Alternative MedicineThe official journal of the International Society for Complementary Medicine Research (ISCMR)201414:58

DOI: 10.1186/1472-6882-14-58

Received: 16 September 2013

Accepted: 13 February 2014

Published: 17 February 2014

Abstract

Background

Spices and herbs have been used in food since ancient times to give taste and flavor and also as food preservatives and disease remedies. In Cameroon, the use of spices and other aromatic plants as food flavoring is an integral part of dietary behavior, but relatively little is known about their antifungal potential.

The present work was designed to assess the antifungal properties of extracts from spices used in Cameroonian dietary.

Methods

The in vitro antifungal activities of twenty three extracts from twenty one spices were assessed by the broth micro-dilution method against eight fungi. Also, the in vivo activity of Olax subscorpioidea extract (the most active extract) was evaluated in rat model of disseminated candidiasis due to Candida albicans by estimating the fungal burden in blood and kidney.

Results

Seven extracts (30%) exhibited moderate to significant antifungal activities, inhibiting the growth of the microorganisms at concentrations ranging from 0.048 to 0.39 mg/mL. Olax subscorpioidea extract exhibited the highest antifungal activity particularly against Candida albicans and Candida tropicalis (MIC of 0.097 mg/mL and 0.048 mg/mL respectively). Sixteen extracts (70%) were weakly active (MICs > 6.25 mg/mL). Oral administration of O. subscorpioidea extract at the dose 2 g/kg of body weight (bw) to artificially infected rats revealed a drop in the number of colony forming units per milliliter (cfu/mL) of Candida albicans cells in the blood below the detection limit (100 cfu/mL) while a modest decrease was observed in the kidney.

Conclusion

The present work shows that some of the spices studied possess interesting antifungal properties and could be used to treat candidiasis. Among the plant species tested, Olax subscorpioidea displayed the most promising result.

Keywords

Antifungal Spices Yeasts Disseminated candidosis

Background

Nowadays, fungal diseases have emerged and are being increasingly recognized as important public health problems owing to an ever-expanding population of immuno-compromised patients [1]. Fungal infections are usually associated with Candida, Aspergillus and Cryptococcus species but those due to Candida species represent the main opportunistic fungal infections worldwide, leading to high morbidity and mortality in the population [2]. These changes are linked to the growing population of immuno-compromised patients. During the last three decades, Candida albicans has been the most prevalent pathogen in systemic fungal infections [3]. Presently non albicans species of Candida account for more than 50% of fungal infections. The opportunistic yeast mostly reported are C. albicans, tropicalis, C. krusei, parapsilosis, C. kefyr, glabrata, C. dubliensis and C. rugosa and Cryptococcus neoformans [4]. Although the antifungal active principles are diverse and numerous, only few classes of antifungal agents are currently available to treat yeast infections due to the high toxicity of many of them [5]. The high morbidity and mortality rates associated with opportunistic yeast infections indicate that current antifungal therapy to combat candidiasis is still ineffective. Furthermore, Pierce and Lopez-Ribot (2013) reported that, the current arsenal of antifungal drugs is exceedingly short and no new antifungal drugs are expected to reach the market any time soon [6]. Therefore, the discovery of new antimicrobial agents is still relevant. Among the potential sources of new agents, plants have long been investigated because they contain many bioactive compounds that can be of interest in therapy. Because of their low toxicity, there is growing interest in using spices as a source of bioactive phytochemicals for their antimicrobial properties in preventing pathogenic diseases, in addition to their flavor and fragrance qualities [7]. Many studies have confirmed the role of spices in health maintenance and promotion; the major challenge is to provide scientific evidence. Therefore intense research have been carried out over the past decade, and scientific evidence is accumulating that spices do have medicinal properties that alleviate symptoms or prevent disease [8, 9]. Many studies have reported the in vitro activities of herbs and spices against several pathogen microorganisms. However, it has been shown that many exciting products found to be highly active on the level of the fungal cell (in vitro activity) were either excessively toxic or inactive when tested in vivo[10]. Therefore, it is essential that the potential effectiveness of the new therapy agent is also evaluated in animal models In Cameroon, the use of spices and other aromatic plants as food flavoring is an integral part of dietary behavior. To the best of our knowledge no study has investigated the effects of Cameroonian spices against eight yeast pathogens. Therefore, the present work was designed to assess the in vitro and in vivo antifungal properties of extracts from selected spices ethno-medicinally used in Cameroon.

Methods

Ethics statement

Animal experiments were performed in this study according to the guidelines set for the care and use of laboratory animals and with the rules formulated under the Animal Welfare Act by the United States Department of Agriculture (USDA) and by adopting ARRIVE guidelines [11].

Plant materials and extraction

The 21 spices investigated in this work were purchased from Dschang local market, West Region of Cameroon in March 2012 (Table 1). They were identified at the Cameroonian National Herbarium where voucher specimens were deposited under the reference number quoted in Table 1. The powdered air-dried sample from each plant was separately extracted with a mixture of methanol-dichloromethane (3:1 V/V) for 48 h at room temperature. The extract was then concentrated under reduced pressure to give the crude extract. All extracts were kept at 4°C until further use.
Table 1

General information on the studied spices

Name of plant (Family)

Ethno-medicinal uses

Parts used

Parts used in this work

Extraction yield (%)

Voucher number

Aframomum citratum (Pereira) K. Schum. (ZINGIBERACEAE)

Fever, intercostals pains, tonic, aphrodisiac [12, 13].

Fruits, barks and leaves

Leaves, fruits

6.12

37736/NHC

Aframomum melegueta (Roscoe) K. Schum. (ZINGIBERACEAE)

Constipation, fever, carminative [14].

Seeds and fruits

Fruits

3.07

39065/HNC

Beilschmiedia cinnamomea (Stapf) Robyns & R. Wilczek(LAURACEAE)

Not reported

Not reported

Barks

5.03

6933/SRF-Cam

Cinnamomum zeylanicum (Linn) Cor. (LAURACEAE)

Stimulant, antiflatulent, antiemetic; antidiarrhoeal [13].

Barks and leaves

Leaves

5.81

22309/SRF-Cam

Dichrostachys glomerata (Forssk.) Chiov. (MIMOSACEAE)

Headache, toothache, dysentery, elephantiasis, leprosy, syphilis, coughs and, anthelmintic, purgative, strong diuretic, epilepsy, diuretic, laxative, and the massage of fractures [15, 16].

Fruits

Fruits

6.68

15220/SRF-Cam

Dorstenia Psilirus Welwitch (MORACEAE)

Arthralgia, cardiovascular disorders, rheumatism, snakebites, headache, stomach disorders, diuretic, tonic, stimulant, analgesic, spice [13].

Leaves and roots

Barks

16.52

44839/HNC

Echinops giganteus var. lelyi (C. D.Adams) A. Rich. (COMPOSITAE)

Heart and gastric troubles spice. Calm stomach ache, give carminative help and reduce the effects of alcohol, reduces asthma attacks [17, 18].

Roots

Roots

2.76

23647/SRF-Cam

Fagara leprieurii (Guill and Perr) Engl (RUTACEAE)

Abdominal pain, asthma, appendicitis, toothache spice. Gastritis, gingivitis. Bilharzias, antidiarrhoeal, cancer, laxative, antimicrobial, ulcer, gonorrhea, kidney ache, sterility [19].

Barks, seeds and fruits

Fruits

5.26

37632/HNC

Fagara macrophylla Engl. (RUTACEAE)

Colds and stomach-ache, fever. Malaria toothache, rheumatism, and urogenital affections [13, 20].

Barks, seeds and fruits

Fruits

17.63

2716/SRFK-Cam

Imperata cylindrica Beauv. var. koenigii Durand et Schinz (POACEAE)

Diuretic and anti-inflammatory agents [21].

Roots

Roots

13.07

30139/SRFK

Mondia whitei Hook. f. (OLACACEAE)

Aphrodisiacs, urinary tract infection, jaundice and headaches diarrhea [22].

Wholes plant, root

Bark of the roots

11.65

42920/HNC

Monodora myristica Dunal (ANNONACEAE)

Constipation, uterine hemorrhage, diuretic, fever [23, 24].

Fruits

Fruits

9.82

2949/SFR-Cam

Olax subscorpioidea var. subscorpioidea Oliv. (OLACACEAE)

Constipation, yellow fever, jaundice, venereal diseases, Guinea worm [25].

Fruits, roots and seeds

Fruits

14.95

3528/SRFK

Pentadiplandra brazzeana Baill. (CAPPARACEAE)

Aphrodisiac, toothache, peptic ulcer, stomach painand hemorrhoids, diarrhea spice [25].

Barks, roots

Barks

3.81

42918/HNC

Piper capense L.f. (PIPERACEAE)

Sleep inducing remedy, anthelmintic, spice [13].

Fruits

Fruits

1.81

6018/SRF-Cam

Piper guineense Schum et Thom (PIPERACEAE)

Respiratory infections, female infertility, aphrodisiac [22].

Fruits

Fruits

10.6

6018/SRF-Cam

Scorodophloeus zenkeri Harms (CAESALPINIACEAE)

Headache, cough, rheumatism; constipation [19].

Barks, seeds, woods, fruits

Bark and fruits

7.67

44803/HNC

Solanum melongena Hierm (SOLANACEAE)

Treatment of syphilis; skin infection; gonorrhea; rheumatic disease and swollen. [14]

Fruits

Fruits

5.26

22615/SRF-Cam

Tetrapleura tetraptera (Schum and Thonn) Taub. (MIMOSACEAE)

Tonic, purgative, emetic, convulsions, leprosy, anti-inflammatroy, rheumatic pains, spice [13, 26].

Fruits and barks

Fruits

3.71

12117/SRF-Cam

Xylopia aethiopica (A. Rich) Dunal (ANNONACEAE)

Headache, cough, rheumatism; constipation [19].

Barks, leaves, roots, fruits

Fruits

18.19

16419/SRF-Cam

Xylopia parviflora (A. Rich.) Benth (ANNONACEAE)

Stomach disorders, barrenness, headache relief, analgesic and antispasmodic [27].

Fruits

Fruits

1.45

6431/SRF-Cam

Fungal strains and culture media

The microorganisms used in this study were Candida albicans ATCC 9002, C. parapsilosis ATCC 22019, C. tropicalis ATCC 750, C. krusei ATCC 6258, C. lusitaniae ATCC 200950, (American Type Culture Collection), Cryptococcus neoformans IP95026 (Institut Pasteur France) and two clinical isolates namely C. guilliermondii and C. glabrata (Centre Pasteur Yaounde-Cameroon). Sabouraud dextrose agar (SDA) (Liofilchem Laboratories) was used for the maintenance and culture of fungal strains while Sabouraud dextrose broth (SDB) was used for the determination of the minimum inhibitory concentrations (MICs) and the minimum fungicidal concentrations (MFCs).

Antifungal assay

MIC and MFC determination

The MICs were determined using the rapid 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyltetrazolium chloride (INT) colorimetric assay [28]. Briefly, extracts were first emulsified in DMSO/SDB (50:50 V/V). The solution obtained was then added to SDB, and serially diluted twofold making each well to have a volume of 100 μL (in a 96- wells microplate). One hundred microlitres (100 μL) of inoculum (2.4 × 104 cfu/mL) prepared in SDB was then added. Wells containing SDB, 100 μL of inoculum and DMSO at a final concentration of 2.5% served as negative control. Nystatin was used as reference antifungal drugs. The plate was covered with a sterile plate sealer, then agitated to mix the contents of the wells using a shaker and incubated at 37°C for 24 h. The final concentration of DMSO was 2.5% and did not affect the microbial growth. The MICs of samples were detected after 24 h (48 h for C. neoformans) incubation at 37°C, following addition of 40 μL of a 0.2 mg/mL INT solution and further incubation at 37°C for 30 minutes. Viable yeast microorganisms reduce the yellow INT dye to pink. MIC was defined as the lowest sample concentration that exhibited complete inhibition of microbial growth and hence prevented this color change. The MFC was determined by adding 50 μL of the suspensions from the wells, which did not show any growth after incubation during MIC assays, to 150 μL of fresh broth. These suspensions were re-incubated at 37°C for 48 h (72 h for C. neoformans). The MFC was determined as the lowest concentration of extract which completely inhibited the growth of yeast.

Effect of O. subscorpioidea extract on disseminated candidiasis in rats

The in vivo antifungal assay was performed as described by Richardson et al., [12] and Kretschmar et al., [13] with slight modifications [29, 30].

Experimental animals: Pathogen-free female albino Wistar rats (6–8 weeks old) were used. These animals were bred in the animal house of the Department of Biochemistry, Faculty of Science of the University of Dschang.

Induction of systemic infection with Candida albicans in rat: Disseminated candidiasis infection was induced by intravenous (i.v.) injection of 0.2 mL of a 106 UFC/mL inoculum, prepared in sterile saline from a fresh 48 h Candida albicans culture to rats. Twenty-four hours after infection three animals were sacrificed to check the effectiveness of the infection by assessing the fungal load in the blood and kidneys. This in vivo study conformed to animal research: reporting in vivo experiment guideline for reporting animal study (ARRIVE).

Antifungal treatment: Infected rats distributed into five groups of 12 animals each were housed in cages and had access to food and water ad libitum. Extract at the doses of 0.5, 1 and 2 g/kg of bw, were administered i.v. over three consecutive days, starting 24 h after infection. Two control groups were used; untreated control received distilled water and a positive control group treated with reference antifungal drug nystatin at 10 mg/kg of bw.

Determination of viable yeasts in organ samples: Twenty-four hours after the first, second and third treatment (at days 2, 3 and 4 of infection) three animals in each group were sacrificed by cervical dislocation; blood and organ samples were collected from each rat. Kidney tissues were homogenized in 5 mL of sterile saline, and then serially diluted. Blood samples were also serially diluted. 0.1 mL of each dilution was plated onto SDA containing chloramphenicol, incubated for 24 h at 37°C and the number of fungal colony were counted. The lower limit of detection was 100 cfu/mL. The results were expressed as log of the mean number of cfu/g of tissue per three animals.

Statistical analysis

One way analysis of variance was used to analyze the fungal load in animal tissues between each treatment group and the control group. When there were differences between groups, the means were compared using the Student-Newman-Keuls test at a 5%. Results are expressed as mean ± standard deviation. All data were analyzed using SPSS Statistics 17.0.2.

Results and discussion

In vitro antifungal activity: Spices have been used for generations by humans as food and to treat ailments. As depicted in Table 1, spices used in this study are used traditionally in the treatment of a wide range of diseases. Many studies have confirmed their role in health maintenance and promotion, but the major challenge is to provide scientific evidence [7]. Therefore, the in vitro and in vivo antifungal potentials of 23 extracts from spices used in Cameroonian dietary were investigated. The results of in vitro antifungal assay (MIC and MBC) are presented in Table 2. The results indicated that all the extracts demonstrated both fungistatic and fungicidal activities with the minimum inhibitory concentration ranging from 0.048 to 6.25 mg/mL and the minimum fungicidal concentration ranging from 0.19 to 6.25 mg/mL. Each of the extract tested in the present study displayed antifungal activity on at least one of the 8 pathogen yeasts tested. However differences were observed between antifungal activities as most of the tested plant extracts exerted a broad antifungal spectrum. These variations in antifungal activity could be due to the differences in the chemical composition of these spices as the secondary metabolites of plants have many effects including antimicrobial properties [31]. In addition, the activity of the plant extract could be influenced by the nature of the plant material or its origin as well as the climatic conditions in which plant grow, the plant part used, or the solvent used for extraction, because plants have different constituents depending on those factors [32].
Table 2

MIC and MFC (mg/mL) of 23 extracts from 21 Cameroonian spices against eight opportunistic yeasts fungi

Tested samples

Microorganisms

Ca

Cn

Ct

Ck

Cp

Cl.

Cgu.

Cgl

MIC

MFC

MIC

MFC

MIC

MFC

MIC

MFC

MIC

MFC

MIC

MFC

MIC

MFC

MIC

MFC

A. citratum (fr)

-

-

6.25

-

6.25

-

-

-

6.25

-

0.78

1.56

3.12

6.25

6.25

-

A. citratum (le)

3.12

-

0.19

6.25

6.25

6.25

0.39

6.25

6.25

-

0.78

0.78

3.12

-

3.12

-

A. melegueta

6.25

-

6.25

-

1.56

1.56

6.25

-

6.25

-

3.12

3.12

1.56

-

-

-

B. cinnamomea

3.12

3.12

3.12

6.25

3.12

-

-

-

-

-

3.12

-

6.25

-

6.25

6.25

C. zeylanicum

3.12

-

1.56

3.12

0.097

0.19

0.78

6.25

3.12

6.25

0.78

0.78

0.78

0.78

3.12

-

D. glomerata

0.39

6.25

0.78

-

3.12

3.12

3.12

3.12

6.25

-

0.39

6.25

3.12

6.25

3.12

6.25

D. psilirus

0.39

1.56

6.25

-

0.39

1.56

3.12

3.12

3.12

3.12

3.12

3.12

1.56

1.56

3.12

-

E. giganteus

6.25

-

3.12

-

6.25

6.25

-

-

6.25

6.25

6.25

6.25

3.12

-

1.56

-

F. leprieurii

3.12

6.25

6.25

6.25

6.25

-

6.25

-

6.25

-

-

-

-

-

3.12

-

F. macrophylla

3.12

6.25

1.56

3.12

0.39

0.78

6.25

-

-

-

1.56

6.25

1.56

-

3.12

-

I. cylindrica

6.25

-

1.56

1.56

3.12

-

1.56

1.56

6.25

-

3.12

3.12

3.12

-

3.12

6.25

M. whitei

3.12

-

-

-

3.12

-

-

-

-

-

3.12

6.25

6.25

-

-

-

M. myristica

6.25

-

0.78

6.25

3.12

3.12

6.25

6.25

-

-

3.12

6.25

3.12

-

-

-

O. subscorpioidea

0.097

0.19

0.39

1.56

0.048

0.19

1.56

6.25

0.39

1.56

0.19

0.39

0.78

-

1.56

6.25

P. brazzeana

3.12

6.25

6.25

6.25

1.56

1.56

-

-

-

-

6.25

-

6.25

-

6.25

-

P. capense

3.12

-

1.56

1.56

0.19

3.12

3.12

6.25

3.12

6.25

1.56

1.56

3.12

-

-

-

P. guineense

3.12

3.12

3.12

-

3.12

-

-

-

6.25

-

1.56

-

-

-

3.12

-

S. zenkeri (fr)

1.56

-

-

-

6.25

-

6.25

-

6.25

6.25

1.56

6.25

6.25

-

3.12

6.25

S. zenkeri (bk)

3.12

-

3.12

-

3.12

-

1.56

6.25

6.25

-

3.12

6.25

6.25

-

6.25

-

S. melongena

-

-

3.1-

-

3.12

3.12

-

-

-

-

-

-

6.25

6.25

-

-

T. tetraptera

3.12

-

3.12

-

6.25

6.25

6.25

-

3.12

6.25

3.12

-

3.12

-

6.25

-

X. aethiopica

3.12

6.25

6.25

6.25

3.12

6.25

3.12

3.12

3.12

3.12

-

-

-

-

-

-

X. parviflora

6.25

-

-

-

3.12

-

3.12

3.12

3.12

3.12

1.56

1.56

3.12

6.25

6.25

-

Nystatin (μg/mL )

78.1

31.2

195.3

78.1

4.8

19.5

6-

1-0

39

156

19.5

78.1

39

78.1

19.5

39

Ca: Candida albicans, Cn: Cryptococcus neoformans, Ct: Candida tropicalis, Ck: Candida krusei, Cp: Candida parapsilosis, Cl: Candida lusitaniae, Cgu: Candida guilliermondii, Cgl: Candida glabrata, fr: fruits, le: leaves, bk: barks. -: > 6.25 mg/mL, le: leaves, fr: fruits, bk: barks, In bold are values for significant activity.

Antimicrobial activity of plant extracts are routinely classified on the basis of susceptibility tests that produce MIC in the range of 100 to 1000 μg/mL [33]. The activity is considered to be significant if MIC values are below 100 μg/mL for crude extract and moderate when the MICs vary from 100 to 625 μg/mL [15, 32]. Seven extracts (30%) inhibited the growth of 6 studied yeasts from significant to moderated extent while other extracts exhibited weak activities. These results are supported by previous studies reporting that the commonly used herbs and spices possess antimicrobial properties that, in some cases, can be used therapeutically [8]. Considering the fact that the spices tested are used as food ingredients with limited toxicity, the overall activity recorded with several extracts, especially those of A. citratum (leaves), D. glomerata, D. psilirus, F. macrophylla and P. capense, could be considered important. The best activity was observed with the extract from O. subscorpioidea fruits showing significant to moderate activity against five out of the eight opportunistic yeast strains tested, with a particular strong effectiveness against Candida albicans and Candida tropicalis (MIC of 0.097 mg/mL and 0.048 mg/mL respectively). The extracts from C. zeylanicum leaves also showed significant activity against Candida tropicalis (MIC of 0.097 mg/mL). High antimicrobial activities of C. zeylanicum against clinical strains of C. albicans from nosocomial infections were previously reported [34]. Qualitative phytochemical analysis of O. subscorpioidea and C. zeylanicum revealed the presence of alkaloids, anthraquinones, phenols, flavonoids, tannins and triterpernes which could contribute to the observed antifungal activities [35]. Many of the phytonutrients found in spices act as potent preventive agents against microbial diseases. It is generally found that plants containing diverse classes of chemicals are of superior biological activities [11]. Thus, it may also be deduced that the higher the diversity and the quantity of these chemical classes a plant may contain, the stronger and broader the spectrum of biological activities the plant molecules may exhibit [36].

Among the eight pathogenic yeasts tested C. albicans and Candida tropicalis were the most sensitive to the extracts, while C. krusei and C. glabrata were the most resistant. Since C. albicans is the most prevalent pathogen in systemic fungal infections [3] and being the most susceptible to O. subscorpioidea extract (MIC of 0.097 mg/mL) in vitro, the in vivo therapeutic effect of O. subscorpioidea extract was evaluated on systemic infection induced with C. albicans in rats.

In vivo antifungal activity: The intravenous challenge model was used to study invasive Candida infection. Yeast cells were injected directly into the blood stream through the lateral tail vein [37]. In this model, which is similar to human invasive infection occurring with catheter involvement, fungal cells are found in all organs, but disease progresses mostly in the kidneys and brain. It is well known that the kidney is the primary target organ in systemic candidiasis; it is the major organ in which the multiplication of Candida occurs [38]. Therefore, the in vivo activity of extract from O. subscorpioidea was evaluated in experimental systemic candidiasis with C. albicans in rats, by estimating the fungal burden in this organ as well as in blood. The results on the estimated number of viable C. albicans cells in blood and kidneys from animals that were infected intravenously with 1×106 cells/mL and treated for three consecutive days with saline, extract (0.5, 1 and 2 g/kg of bw) are shown in Figures 1. The administration of the extract caused a reduction of the fungal load after 24 h both in the blood and in kidneys of infected rats compare to untreated control. A significant difference was observed (p < 0.05) in the decrease of fungal load in blood at 2 g/mg of bw with respect to the control (Figure 1A). At this extract concentration, the number of cfu/mL in blood dropped below the detection limit within 72 h, while the control (nystatin) showed similar effect within 48 h. This result suggests that C. albicans cells intravenously injected were rapidly cleared from the blood. The rapid disappearance of C. albican s from the blood observed could be attributed to the combined killing effect of extract or nystatin and the immune system cells. Our findings are in agreement with those of Robert et al. [39], who reported that after injection into the lateral tail veins of mice, the rate of clearance of C. albicans from the bloodstream was high, leading to the disappearance of 97% of the inoculated cells within the first minute. It should also be noted that this observation could be explained further by the fact that some of the C. albicans cells moved into the deep organs like the kidneys, being the primary target organ in systemic candidiasis where the multiplication of C. albicans occurs [38]. As shown in Figure 1B, compared to untreated infected animals, extract reduced the level of fungal load in kidneys during treatment. After 3 days of treatment with extract each of the test doses modestly reduced the growth of fungi in the kidney. At the highest dose (2 g/kg of bw), reduction in the log of cfu/g in the kidney was more pronounced compared to the lower doses. Although the reduction was not statistically significant, the result obtained is important when compared to those obtained with nystatin. Nevertheless, it is noteworthy that the result obtained could be considered as significant bearing in mind that C. albicans survival in the kidney plays a primary role in mortality in patients with disseminated candidiasis [40]. Our results revealed that extract from O. subscorpioidea displayed an inhibitory effect on fungal proliferation in vivo. To the best of our knowledge, the in vivo antifungal properties of spices are herein reported for the first time. Therefore, a subject for future investigation with a possible prolongation of the period of treatment to 7 or 14 days to more accurately define the preclinical significance of the in vivo data herein observed.
https://static-content.springer.com/image/art%3A10.1186%2F1472-6882-14-58/MediaObjects/12906_2013_Article_1658_Fig1_HTML.jpg
Figure 1

Variation of fungal burden of blood (A) and kidney (B) in rat model of disseminated candidiasis at various time intervals upon treatment with extract Olax subscorpioidea and nystatin. Animals were infected intravenously with 106 cells/mL(Candida albicans) and were treated for three consecutive days with saline, extract (0.5, 1 and 2 g/kg of bw) and nystatin (10 mg/kg of bw). The fungal burden was assessed by determining the number of cfu.

The overall results obtained revealed that, extract from spices in this study possess inhibitory effect on the growth of pathogenic yeast. Olax subscorpioidea showed the most promising activity in vitro and exerted interesting anti-Candida effect against systemic candidiasis in rat model. These findings emphasize the evidence that increasing our intake in spices could be an alternative to prevention of infections from opportunistic fungal yeast pathogens.

Conclusion

The present study demonstrates the antifungal potential of extracts from some Cameroonian spices and provides the scientific evidence that natural spices could be used for the prevention of yeast diseases.

Declarations

Acknowledgements

JP Dzoyem is thankful to ”The World Academy of Sciences (TWAS) for the advancement of science in developing countries” for funding this work throught the TWAS Research Grant Agreement No:11–128 RG/CHE/AF/AC_UNESCO FR:3240262681, 2012.

Authors’ Affiliations

(1)
Department of Biochemistry, Faculty of Science, University of Dschang
(2)
Department of Biomedical Sciences, Faculty of Health Sciences, University of Bamenda

References

  1. Miceli MH, Diaz JA, Lee SA: Emerging opportunistic yeast infections. Lancet Infect Dis. 2011, 11: 142-151. 10.1016/S1473-3099(10)70218-8.View ArticlePubMedGoogle Scholar
  2. Low CY, Rotstein C: Emerging fungal infections in immunocompromised patients. F1000 Med Rep. 2011, 3: 14-View ArticlePubMedPubMed CentralGoogle Scholar
  3. Pfaller MA, Diekema DJ: Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol. 2004, 42: 4419-4431. 10.1128/JCM.42.10.4419-4431.2004.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Banerje U: Opportunistic pathogenic yeasts. Yeast Biotechnology: Diversity and Applications. Part I. Edited by: Satyanarayana T, Kunze G. 2009, Netherlands: Springer, 215-236.View ArticleGoogle Scholar
  5. Spampinato C, Leonardi D: Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agents. BioMed Res Int. 2013, 204237-Google Scholar
  6. Pierce CG, Lopez-Ribot JL: Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs. Expert Opin Drug Discov. 2013, 8: 1117-1126. 10.1517/17460441.2013.807245.View ArticlePubMedPubMed CentralGoogle Scholar
  7. Arora DS, Kaur J: Antimicrobial activity of spices. Int J Antimicrob Agents. 1999, 12: 257-262. 10.1016/S0924-8579(99)00074-6.View ArticlePubMedGoogle Scholar
  8. Lai PK, Roy J: Antimicrobial and chemopreventive properties of herbs and spices. Curr Med Chem. 2004, 11: 1451-1460. 10.2174/0929867043365107.View ArticlePubMedGoogle Scholar
  9. Naser AAW: Antimicrobial and antioxidant properties of spices. Bull Pharm Sci, Assiut University. 2007, 30: 81-87.Google Scholar
  10. Polak A: Experimental models in antifungal chemotherapy. Mycoses. 1998, 41: 1-30.View ArticlePubMedGoogle Scholar
  11. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG: Animal research: reporting in vivo experiments_the ARRIVE guidelines. J Cereb Blood Flow Metab. 2011, 31: 991-993. 10.1038/jcbfm.2010.220.View ArticlePubMedPubMed CentralGoogle Scholar
  12. Tane P, Tatsimo SD, Ayimele GA, Connolly JD: Bioactive metabolites from Aframomum species. 2005, Antananarivo, Madagascar: 11th NAPRECA Symposium Book of Proceedings, 214-223.Google Scholar
  13. Kuete V, Krusche B, Youns M, Voukeng I, Fankam AG, Tankeo S, Lacmata S, Efferth T: Cytotoxicity of some Cameroonian spices and selected medicinal plant extracts. J Ethnopharmacol. 2011, 134: 803-812. 10.1016/j.jep.2011.01.035.View ArticlePubMedGoogle Scholar
  14. Dalziel JM: The useful plants of west tropical Africa. 1937, London: Crown Agents for the ColoniesGoogle Scholar
  15. Kuete V: Potential of Cameroonian plants and derived products against microbial infections: a review. Planta Med. 2010, 76: 1479-1491. 10.1055/s-0030-1250027.View ArticlePubMedGoogle Scholar
  16. Gisèle GAK, Dzeufiet DD, Foyet HS, Nana P, Sokeng CD, Dimo T, Kamtchouing P: Analgesic and anti-inflammatory activities of Dichrostachys glomerata (forssk.) hutch. fruits methanolic extract in rats. J Phys Pharm Adv. 2012, 2: 269-276.Google Scholar
  17. Menut C, Lamaty G, Weyerstahl P, Marschall H, Seelmann I, Amvam Zollo PH: Aromatic plants of tropical central Africa. Part XXXI. Tricyclic sesquiterpenes from the root essential oil of Echinops giganteus var. lelyi C. D. Adams. Flavour Fragrance J. 1997, 12: 415-421. 10.1002/(SICI)1099-1026(199711/12)12:6<415::AID-FFJ666>3.0.CO;2-T.View ArticleGoogle Scholar
  18. Tene M, Tane P, Sondengam BL, Connolly JD: Lignans from the roots of Echinops giganteus. Phytochemistry. 2004, 65: 2101-2105. 10.1016/j.phytochem.2004.05.014.View ArticlePubMedGoogle Scholar
  19. Ngono Ngane A, Biyiti L, Amvam Zollo PH, Bouchet P: Evaluation of antifungal activity of extracts of two Cameroonian Rutaceae: Zanthoxylum leprieurii Guill. et Perr. and Zanthoxylum xanthoxyloides Waterm. J Ethnopharmacol. 2000, 70: 335-342. 10.1016/S0378-8741(99)00188-9.View ArticleGoogle Scholar
  20. Irvine FR: Woody plants of Ghana. 1961, Oxford University PressGoogle Scholar
  21. Nishimot K, Ito M, Natori S, Ohmoto T: Structures of Arundoin Cylindrin and Fernenol - Triterpenoids of Fernane and Arborane Groups of Imperata Cylindrica Var Koenigii. Tetrahedron. 1968, 24: 735-752. 10.1016/0040-4020(68)88023-8.View ArticleGoogle Scholar
  22. Noumi E, Zollo PHA, Lontsi D: Aphrodisiac plants used in Cameroon. Fitoterapia. 1998, 69: 125-134.Google Scholar
  23. Tatsadjieu LN, Ngang JJE, Ngassoum MB, Etoa FX: Antibacterial and antifungal activity of Xylopia aethiopica, Monodora myristica, Zanthoxylum xanthoxyloides and Zanthoxylum leprieurii from Cameroon. Fitoterapia. 2003, 74: 469-472. 10.1016/S0367-326X(03)00067-4.View ArticlePubMedGoogle Scholar
  24. Okafor JC: Development of forest tree crops for food supplies in Nigeria. Forest Ecol Manag. 1978, 1: 235-247.View ArticleGoogle Scholar
  25. Okoli RI, Aigbe O, Ohaju-Obodo JO, Mensah JK: Medicinal herbs used for managing some common ailments among Esan people of Edo State, Nigeria. Pak J Nutr. 2007, 6: 490-496. 10.3923/pjn.2007.490.496.View ArticleGoogle Scholar
  26. Tekwu EM, Askun T, Kuete V, Nkengfack AE, Nyasse B, Etoa F, Beng VP: Antibacterial activity of selected Cameroonian dietary spices ethno-medically used against strains of Mycobacterium tuberculosis. J Ethnopharmacol. 2012, 142: 374-382. 10.1016/j.jep.2012.05.003.View ArticlePubMedGoogle Scholar
  27. Nishiyama Y, Moriyasu M, Ichimaru M, Iwasa K, Kato A, Mathenge SG, Mutiso PBC, Juma FD: Antinociceptive effects of the extracts of Xylopia parviflora bark and its alkaloidal components in experimental animals. J Nat Med-Tokyo. 2010, 64: 9-15. 10.1007/s11418-009-0356-2.View ArticleGoogle Scholar
  28. Eloff JN: A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Med. 1998, 64: 711-713. 10.1055/s-2006-957563.View ArticlePubMedGoogle Scholar
  29. Richardson K, Brammer KW, Marriott MS, Troke PF: Activity of Uk-49,858, a Bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes. Antimicrob Agents Chemother. 1985, 27: 832-835. 10.1128/AAC.27.5.832.View ArticlePubMedPubMed CentralGoogle Scholar
  30. Kretschmar M, Amselem S, Zawoznik E, Mosbach K, Dietz A, Hof H, Nichterlein T: Efficient treatment of murine systemic infection with Candida albicans using amphotericin B incorporated in nanosize range particles (emulsomes). Mycoses. 2001, 44: 281-286. 10.1111/j.1439-0507.2001.00654.x.View ArticlePubMedGoogle Scholar
  31. Cowan MM: Plant products as antimicrobial agents. Clin Microbiol Rev. 1999, 12: 564-582.PubMedPubMed CentralGoogle Scholar
  32. Ncube NS, Afolayan AJ, Okoh AI: Assessment techniques of antimicrobial properties of natural compounds of plant origin: current methods and future trends. Afr J Biotechnol. 2008, 7: 1797-1806.View ArticleGoogle Scholar
  33. Simoes M, Bennett RN, Rosa EAS: Understanding antimicrobial activities of phytochemicals against multidrug resistant bacteria and biofilms. Nat Prod Rep. 2009, 26: 746-757. 10.1039/b821648g.View ArticlePubMedGoogle Scholar
  34. Khan R, Islam B, Akram M, Shakil S, Ahmad A, Ali SM, Siddiqui M, Khan AU: Antimicrobial activity of five herbal extracts against multi drug resistant (MDR) strains of bacteria and fungus of clinical origin. Molecules. 2009, 14: 586-597. 10.3390/molecules14020586.View ArticlePubMedGoogle Scholar
  35. Fankam AG, Kuete V, Voukeng IK, Kuiate JR, Pages JM: Antibacterial activities of selected Cameroonian spices and their synergistic effects with antibiotics against multidrug-resistant phenotypes. BMC Complement Altern Med. 2011, 11: 104-10.1186/1472-6882-11-104.View ArticlePubMedPubMed CentralGoogle Scholar
  36. Wangchuk P, Keller PA, Pyne SG, Taweechotipatr M, Tonsomboon A, Rattanajak R, Kamchonwongpaisan S: Evaluation of an ethnopharmacologically selected Bhutanese medicinal plants for their major classes of phytochemicals and biological activities. J Ethnopharmacol. 2011, 137: 730-742. 10.1016/j.jep.2011.06.032.View ArticlePubMedGoogle Scholar
  37. Papadimitriou JM, Ashman RB: The pathogenesis of acute systemic candidiasis in a susceptible inbred mouse strain. J Pathol. 1986, 150: 257-265. 10.1002/path.1711500405.View ArticlePubMedGoogle Scholar
  38. Baine WB, Koenig MG, Goodman JS: Clearance of Candida albicans from blood-stream of rabbits. Infect Immun. 1974, 10: 1420-1425.PubMedPubMed CentralGoogle Scholar
  39. Robert R, Nail S, Marot-Leblond A, Cottin J, Miegeville M, Quenouillere S, Mahaza C, Senet JM: Adherence of platelets to Candida species in vivo. Infect Immun. 2000, 68: 570-576. 10.1128/IAI.68.2.570-576.2000.View ArticlePubMedPubMed CentralGoogle Scholar
  40. Bendel CM, Kinneberg KM, Jechorek RP, Gale CA, Erlandsen SL, Hostetter MK, Wells CL: Systemic infection following intravenous inoculation of mice with Candida albicans int1 mutant strains. Mol Genet Metab. 1999, 67: 343-351. 10.1006/mgme.1999.2875.View ArticlePubMedGoogle Scholar
  41. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/14/58/prepub

Copyright

© Dzoyem et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.